219 related articles for article (PubMed ID: 26830551)
21. Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease.
Laforêt P; Petiot P; Nicolino M; Orlikowski D; Caillaud C; Pellegrini N; Froissart R; Petitjean T; Maire I; Chabriat H; Hadrane L; Annane D; Eymard B
Neurology; 2008 May; 70(22):2063-6. PubMed ID: 18505979
[TBL] [Abstract][Full Text] [Related]
22. Auditory system involvement in late onset Pompe disease: a study of 20 Italian patients.
Musumeci O; Catalano N; Barca E; Ravaglia S; Fiumara A; Gangemi G; Rodolico C; Sorge G; Vita G; Galletti F; Toscano A
Mol Genet Metab; 2012 Nov; 107(3):480-4. PubMed ID: 22958975
[TBL] [Abstract][Full Text] [Related]
23. Restrictive Arteriopathy in Late-Onset Pompe Disease: Case Report and Review of the Literature.
Malhotra K; Carrington DC; Liebeskind DS
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):e172-e175. PubMed ID: 28647415
[TBL] [Abstract][Full Text] [Related]
24. An integrative correlation of myopathology, phenotype and genotype in late onset Pompe disease.
Kulessa M; Weyer-Menkhoff I; Viergutz L; Kornblum C; Claeys KG; Schneider I; Plöckinger U; Young P; Boentert M; Vielhaber S; Mawrin C; Bergmann M; Weis J; Ziagaki A; Stenzel W; Deschauer M; Nolte D; Hahn A; Schoser B; Schänzer A
Neuropathol Appl Neurobiol; 2020 Jun; 46(4):359-374. PubMed ID: 31545528
[TBL] [Abstract][Full Text] [Related]
25. The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients.
Feeney EJ; Austin S; Chien YH; Mandel H; Schoser B; Prater S; Hwu WL; Ralston E; Kishnani PS; Raben N
Acta Neuropathol Commun; 2014 Jan; 2():2. PubMed ID: 24383498
[TBL] [Abstract][Full Text] [Related]
26. Bright tongue sign in patients with late-onset Pompe disease.
Karam C; Dimitrova D; Yutan E; Chahin N
J Neurol; 2019 Oct; 266(10):2518-2523. PubMed ID: 31256280
[TBL] [Abstract][Full Text] [Related]
27. A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease.
Byrne BJ; Geberhiwot T; Barshop BA; Barohn R; Hughes D; Bratkovic D; Desnuelle C; Laforet P; Mengel E; Roberts M; Haroldsen P; Reilley K; Jayaram K; Yang K; Walsh L;
Orphanet J Rare Dis; 2017 Aug; 12(1):144. PubMed ID: 28838325
[TBL] [Abstract][Full Text] [Related]
28. The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management.
Kishnani PS; Beckemeyer AA; Mendelsohn NJ
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):1-7. PubMed ID: 22253049
[TBL] [Abstract][Full Text] [Related]
29. Correlation of acid alpha-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease.
Umapathysivam K; Hopwood JJ; Meikle PJ
Clin Chim Acta; 2005 Nov; 361(1-2):191-8. PubMed ID: 15993875
[TBL] [Abstract][Full Text] [Related]
30. Potential patient screening for late-onset Pompe disease in suspected sleep apnea: a rationale and study design for a Prospective Multicenter Observational Cohort Study in Japan (PSSAP-J Study).
Yamauchi M; Nakayama H; Shiota S; Ohshima Y; Terada J; Nishijima T; Kosuga M; Kitamura T; Tachibana N; Oguri T; Shirahama R; Aoki Y; Ishigaki K; Sugie K; Yagi T; Muraki H; Fujita Y; Takatani T; Muro S
Sleep Breath; 2021 Jun; 25(2):695-704. PubMed ID: 32808237
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of adult Pompe disease in patients with proximal myopathic syndrome and undiagnosed muscle biopsy.
Golsari A; Nasimzadah A; Thomalla G; Keller S; Gerloff C; Magnus T
Neuromuscul Disord; 2018 Mar; 28(3):257-261. PubMed ID: 29326002
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing.
Lévesque S; Auray-Blais C; Gravel E; Boutin M; Dempsey-Nunez L; Jacques PE; Chenier S; Larue S; Rioux MF; Al-Hertani W; Nadeau A; Mathieu J; Maranda B; Désilets V; Waters PJ; Keutzer J; Austin S; Kishnani P
Orphanet J Rare Dis; 2016 Jan; 11():8. PubMed ID: 26809617
[TBL] [Abstract][Full Text] [Related]
33. Reveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe Disease.
Peng J; Dalton J; Butt M; Tracy K; Kennedy D; Haroldsen P; Cahayag R; Zoog S; O'Neill CA; Tsuruda LS
J Pharmacol Exp Ther; 2017 Feb; 360(2):313-323. PubMed ID: 27856936
[TBL] [Abstract][Full Text] [Related]
34. Clinical manifestations and acid alpha-glucosidase mutation characterisation of a cohort of patients with late-onset Pompe disease in eastern China.
Zhao HH; Ma Z; Ying ZX; Niu FN; Luo MT; Wang Z; Cheng X; Zhang QQ; Niu Q
Ann Transl Med; 2021 Dec; 9(24):1803. PubMed ID: 35071497
[TBL] [Abstract][Full Text] [Related]
35. Screening for late-onset Pompe disease in Internal Medicine departments in Spain.
López-Rodríguez M; Torralba-Cabeza MA; de Pedro IP; Rivera A; Gil RS; Gómez-Belda A; de la Peña JLP; de Los Santos Moreno A; Selva-O'Callaghan A; Gárate IG; García AG; Hurtado R; de Ureta PT; Barba-Romero MÁ; Milisenda JC; Grau-Junyent JM;
Orphanet J Rare Dis; 2023 Aug; 18(1):256. PubMed ID: 37653444
[TBL] [Abstract][Full Text] [Related]
36. Expanding the clinical spectrum of late-onset Pompe disease: dilated arteriopathy involving the thoracic aorta, a novel vascular phenotype uncovered.
El-Gharbawy AH; Bhat G; Murillo JE; Thurberg BL; Kampmann C; Mengel KE; Kishnani PS
Mol Genet Metab; 2011 Aug; 103(4):362-6. PubMed ID: 21605996
[TBL] [Abstract][Full Text] [Related]
37. [A retrospective study of six patients with late-onset Pompe disease].
Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
[TBL] [Abstract][Full Text] [Related]
38. Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study.
van der Ploeg A; Carlier PG; Carlier RY; Kissel JT; Schoser B; Wenninger S; Pestronk A; Barohn RJ; Dimachkie MM; Goker-Alpan O; Mozaffar T; Pena LD; Simmons Z; Straub V; Guglieri M; Young P; Boentert M; Baudin PY; Wens S; Shafi R; Bjartmar C; Thurberg BL
Mol Genet Metab; 2016 Sep; 119(1-2):115-23. PubMed ID: 27473031
[TBL] [Abstract][Full Text] [Related]
39. Molecular analysis and protein processing in late-onset Pompe disease patients with low levels of acid α-glucosidase activity.
Bali DS; Tolun AA; Goldstein JL; Dai J; Kishnani PS
Muscle Nerve; 2011 May; 43(5):665-70. PubMed ID: 21484825
[TBL] [Abstract][Full Text] [Related]
40. Fat and carbohydrate metabolism during exercise in late-onset Pompe disease.
Preisler N; Laforet P; Madsen KL; Hansen RS; Lukacs Z; Ørngreen MC; Lacour A; Vissing J
Mol Genet Metab; 2012 Nov; 107(3):462-8. PubMed ID: 22981821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]